MOSCOW (Reuters) - Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.
The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.
When news broke last week that a man living in Hong Kong had been infected with the coronavirus again, months after recovering from a previous bout of COVID-19, immunologist Akiko Iwasaki had an unusual reaction. “I was really kind of happy,” she says. “It’s a nice textbook example of how the immune response should work.”
The U.S. will not join a global initiative to secure and distribute a coronavirus vaccine led by the World Health Organization and others, according to a White House official.
A closer look at the Bradykinin hypothesis
Earlier this summer, the Summit supercomputer at Oak Ridge National Lab in Tennessee set about crunching data on more than 40,00
Do masks really work? Ask the dozens of Starbucks customers who tested positive for COVID-19 in Seoul this month after a woman with coronavirus sat under one of the cafe’s air-conditioners.
According to a local news report, at least 56 coronavirus cases have been linked to that one customer. The kicker: The four masked workers avoided infection.
A Nevada resident is thought to be the first person in the United States to be infected twice by the coronavirus, according to findings released this week.
The 25-year-old man, of Reno, experienced a sore throat, cough, headache, nausea and diarrhea — and first tested positive for the COVID-19 on April 18, according to a study published to the website SSRN Thursday, which has yet to be peer-reviewed.
The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn't need any special computer equipment to get results.
The 15-minute BinaxNOW test from Abbott Laboratories will sell for $5, giving it a competitive edge over similar tests that need to be popped into a small machine. The self-contained test is the size of a credit card and is based on the same technology used to test for the flu, strep throat and other infections.
AMSTERDAM/BRUSSELS (Reuters) - Two European patients are confirmed to have been re-infected with COVID-19, raising concerns about people’s immunity to the coronavirus as the world struggles to tame the pandemic.
The cases, in Belgium and the Netherlands, follow a report this week by researchers in Hong Kong about a man there who had contracted a different strain of the virus four and a half months after being declared recovered - the first such second infection to be documented.